Presentation
Scientific Publications
-
2025Journal (source)Blood Cancer J
Telomere occupancy by TRF2 is altered by KIT mutations and correlates with ma...
-
2025Journal (source)openRxiv
AXL mediates mast cell survival and resistance to tyrosine kinase inhibitors ...
-
2024Journal (source)Nat Commun
Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenviron...
-
2024Journal (source)Cancer Res
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes ...
-
2023Journal (source)Leukemia
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an...
-
2023Journal (source)Leukemia
Exploring the genetic landscape of HCV-related B-cell lymphomas using whole e...
-
2023Journal (source)Br J Haematol
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparagin...
-
2021Journal (source)Am J Hematol
Outcome after hematopoietic stem cell transplantation in patients with extran...
-
2021Journal (source)Blood
Inherited glycosylphosphatidylinositol defects cause the rare Emm-negative bl...
-
2021Journal (source)Lab Invest
Feline low-grade intestinal T cell lymphoma: a unique natural model of human ...
-
2020Journal (source)Leukemia
Targeted deep sequencing reveals clonal and subclonal mutational signatures i...
-
2020Journal (source)J Allergy Clin Immunol
Improving the diagnostic efficiency of primary immunodeficiencies with target...
-
2020Journal (source)Front Microbiol
Novel Treatments of Adult T Cell Leukemia Lymphoma.
-
2020Journal (source)Blood
Topoisomerase 2β mutation impairs early B-cell development.
-
2020Journal (source)Haematologica
Innate immune cells, major protagonists of sickle cell disease pathophysiology.
-
2019Journal (source)F1000Res
Recent advances in the understanding and therapeutic management of mastocytosis.
-
2019Journal (source)Haematologica
A novel, highly potent and selective phosphodiesterase-9 inhibitor for the tr...
-
Journal (source)J Allergy Clin Immunol Pract
Neuroinflammatory disorders and mastocytosis: A possible association?
-
Journal (source)J Allergy Clin Immunol Pract
Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, ...
-
2019Journal (source)Front Immunol
Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected C...
-
2019Journal (source)Leukemia
Frequent structural variations involving programmed death ligands in Epstein-...
-
2018Journal (source)Gastroenterology
Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associ...
-
2018Journal (source)Gut
NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointe...
-
2018Journal (source)Am. J. Hum. Genet.
Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegenerati...
-
2018Journal (source)Clin. Immunol.
Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency...
-
2017Journal (source)Nature communications
Type I interferon-mediated autoinflammation due to DNase II deficiency.
-
2017Journal (source)Nat Med
Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation...
-
2017Journal (source)Transl Psychiatry
Neuroimaging evidence of brain abnormalities in mastocytosis.
-
2015Journal (source)Cell Death Dis
AK2 deficiency compromises the mitochondrial energy metabolism required for d...
-
2012Journal (source)Haematologica
Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency...
-
2011Journal (source)Blood
A survey of 90 patients with autoimmune lymphoproliferative syndrome related ...
-
2010Journal (source)Gastroenterology
Reduced expression of FOXP3 and regulatory T-cell function in severe forms of...
-
2009Journal (source)Blood
FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are relia...